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Objectives. The purpose of this retrospective study was to 
compare the results of transluminai extraction coronary atherec- 
tomy in saphenous vein graft lesions with and without angio- 
graphic thrombus. 
Background. Percutaneous interventions in lesions with throm- 
bus are associated with reduced procedural success and increased 
risk of complications. Use of the transluminal extraction catheter, 
which cuts and aspirates atheroma nd thrombus, has been 
advocated as a potential revascularization strategy for lesions 
with thrombus. 
Methods. Baseline patient characteristics, lesion morphology, 
immediate angiographic results, in-hospital complications and 
follow-up were prospectively entered into an interventional cardi- 
ology data base. The results of transluminai extraction coronary 
atherectomy in saphenous vein bypass grafts with angiographic 
thrombus were compared with results in similar grafts without 
angiographic thrombus. 
Results. Transluminal extraction coronary atherectomy was 
performed in 175 patients with 183 vein graft lesions, including 59 
lesions (32%) with thrombus (Group 1) and 124 (68%) without 
thrombus (Group 2). Compared with lesions in Group 2, lesions 
in Group 1 were associated with a higher incidence of baseline 
total occlusion, diffuse disease and abnormal Thrombolysis in 
Myocardial Infarction (TIMI) grade flow (p < 0.05); more severe 
diameter stenosis at baseline, after atherectomy and after final 
angiography (p < 0.05); a lower rate of clinical success (69% vs. 
88%, p < 0.01); and more angiographic and clinical complica- 
tions, including no reflow (p < 0.05), vascular epair (p < 0.05) 
and Q wave myocardial infarction (p = 0.09). 
Conclusions. In transluminal extraction coronary atherectomy 
of saphenous vein bypass grafts, the presence of thrombus is 
associated with more baseline lesion complexity, reduced clinical 
success and increased risk of no reflow, Q wave myocardial 
infarction and vascular epair. 
(J Am CoU Cardiol 1995;25:1700-5) 
Percutaneous coronary revascularization in the presence of 
thrombus or in clinical settings where thrombus i likely to be 
present is associated with increased risk of abrupt vessel 
closure, myocardial infarction, emergency oronary artery by- 
pass surgery and death (1-3). The importance of angiographic 
thrombus was recognized in the American Heart Association/ 
American College of Cardiology Guidelines for Percutaneous 
Transluminal Coronary Angioplasty (4). 
Saphenous vein bypass grafts >4 years of age frequently 
contain thrombus (5-7). Percutaneous intervention i these 
lesions is associated with higher isks of distal embolization, o 
reflow and myocardial infarction than those associated with 
interventions in native coronary arteries (8,9). The translumi- 
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nal extraction catheter is a new percutaneous interventional 
device that may have a role in thrombotic lesions (10) by virtue 
of its ability to cut and aspirate atheroma nd thrombus. The 
aim of this study was to determine the impact of thrombus on 
immediate results and complications for transluminal extrac- 
tion coronary atherectomy of old saphenous vein bypass graft 
lesions. 
Methods  
Atherectomy procedure. Between 1989 and 1993, translu- 
minal extraction coronary atherectomy of saphenous vein 
bypass grafts was performed in 183 lesions in 175 consecutive 
patients with a mean age of 65 _+ 12 years. The immediate 
results, complications and follow-up of the first 146 patients 
were previously reported (11). All procedures were performed 
in accordance with a protocol approved by the Human Inves- 
tigations Committee of William Beaumont Hospital, as previ- 
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ously described (11). Device selection, use of intracoronary 
thrombolytic agents and adjunctive balloon angioplasty were 
used at the discretion of the operator. Since 1991, the results of 
percutaneous coronary interventions have been prospectively 
entered into the William Beaumont Hospital Interventional 
Cardiology Database with. the use of a standard case report 
form. Interventions performed before 1991 were entered ret- 
rospectively into the data base. 
Angiographic assessment. Assessment of baseline lesion 
characteristics and quantitative angiography using digital cali- 
pers was performed as previously described (11). Thrombus 
was defined as a definite circumscribed intraluminat filling 
defect on baseline angiography, whereas intraluminal haziness 
alone was not considered sufficient evidence for thrombus. 
• Measurements were made of minimal lumen diameter, efer- 
ence diameter and lesion length; percent diameter stenosis was 
calculated by using standard formulas. 
Definitions. The following definitions were used: Angio- 
graphic success = final diameter stenosis <50%; clinical suc- 
cess = final diameter stenosis <50% in the absence of death, 
emergency bypass urgery or Q wave myocardial infarction; 
distal embolization = new appearance of circumscribed filling 
defects or abrupt cutoff of the vessel distal to the target lesion, 
or both; no reflow = poor anterograde flow (Thrombolysis n 
Myocardial Infarction [TIMI] grade _<1) not explained by 
dissection or high grade residual stenosis at or adjacent to the 
target lesion; abrupt closure = poor anterograde flow (TIMI 
grade _<1) due to acute occlusion of the target lesion; non-Q 
wave myocardial infarction = elevation of creatine kinase >3 
times the upper limit of normal in the absence of pathologic Q
waves; sizing index = the ratio of the final device diameter to 
the reference artery diameter (D/A ratio) or the ratio of the 
final balloon diameter to the reference artery diameter (B/A 
ratio), as previously described (12); efficiency of transluminal 
extraction coronary atherectomy or balloon-mediated lumen 
enlargement = the ratio of the residual lumen diameter after 
atherectomy to the final device diameter (RLD/D) or the ratio 
of the final lumen diameter after angioplasty to the final 
balloon diameter (FED/B), as previously described (12). 
End points. End points included procedural success, an- 
giographic complications (abrupt closure, no reflow, distal 
embolization and perforation) and clinical complications 
(death, myocardial infarction, vascular epair, blood transfu- 
sion, stroke). Clinical follow-up was obtained for patients 
discharged from the hospital after successful revascutarization. 
Late events included eath, myocardial infarction and the need 
for target vessel revascularization (repeat percutaneous inter- 
vention or bypass urgery). Angiography was recommended to 
all patients with recurrent symptoms. 
Statistical analyses• Data are reported as mean value + 
SD. Comparisons were performed using the Student t test for 
continuous variables and the Fisher exact test for categoric 
variables with small observed frequencies (JMP software, SAS 
Institute). 
Table 1. Baseline Characteristics of Patients Treated With 
Transluminal Extraction Coronary Atherectomy in Vein Grafts 
Total Group 1 Group 2 
(n = 183) (n = 59) (n = 124) 
Age (yr) 65 -+ 9 64 + 10 65 + 9 
Male 83% 85% 73% 
CCS Angina class IV 47% 56% 43% 
Acute MI* 3% 8% 0% 
LVEF (%) 47 -+ 13% 45 _+ 12% 48 _+ 14% 
SVG age (yr) 8.2 _+ 0.4 8.6 _+ 0.5 8.0 _+ 0.3 
*p < 0.01, comparing Group 1 and Group 2. Data are expressed as mean 
value +- SD or percent of group. CCS = Canadian Cardiovascular Society; 
LVEF = left ventricular ejection fraction; MI = myocardial infarction; SVG = 
saphenous vein graft. 
Resu l ts  
Baseline characteristics. The 175 study patients were clas- 
sified into two groups: Group 1 (n = 59 lesions, 32%) with 
thrombus and Group 2 (n = 124 lesions, 68%) without 
thrombus. The two groups were similar in age, gender distri- 
bution, Canadian Cardiovascular Society angina class, left 
ventricular ejection fraction and vein graft age (Table 1). The 
indication for percutaneous revascularization was acute myo- 
cardial infarction in five patients (8%) in Group 1 in contrast 
to no patients in Group 2 (p < 0.01). 
Angiographic results. Baseline angiography revealed a sig- 
nificantly higher incidence of baseline total occlusion (17% vs. 
6%, p < 0.05), diffuse disease (71% vs. 43%, p < 0.05) and 
delayed anterograde flow (53% vs. 16%, p < 0.05) in Group 1 
than in Group 2 but a lower frequency of aortoostial lesions 
(7% vs. 23%, p < 0.05) (Table 2). Adjunctive percutaneous 
transluminal coronary angioplasty was used in 92% of lesions 
and was similar for both groups. Despite similar reference 
vessel diameters in the two groups of lesions, quantitative 
angiography revealed more severe diameter stenoses in Group 
1 than in Group 2 (p < 0.05), including those at baseline, after 
extraction coronary atherectomy and after final angiography 
(with or without adjunctive angioplasty) (Table 3). These 
findings may be partially explained by the smaller D/A and B/A 
Table 2. Qualitative Angiographic Characteristics of Vein Graft 
Lesions Treated With Transluminal Extraction Coronary Atherectomy 
Group 1 Group 2 
(n = 59) (n = 124) 
No. % No. % 
Multivessel disease 59 100 124 100 
Aorto-ostial* 4 7 29 23 
Total occlusion* 10 17 7 6 
Eccentric 32 54 80 64 
Ulceration 6 10 20 16 
Diffuse disease* 40 71 52 43 
Baseline TIMI flow grade 3* 28 47 104 84 
Final TIMI flow grade 3* 38 64 113 91 
*p < 0.05, comparing Group 1 and Group 2. TIMI = Thrombolysis in 
Myocardial Infarction. 
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Table 3. Quantitative Angiographic Results of Vein Graft Lesions 
Treated With Transluminal Extraction Coronary Atherectomy 
Group 1 Group 2 
(n - 59) (n = 124) 
Reference diameter (mm) 3.91 _+ 0.1 3.68 _+ 0.1 
Lumen diameter (mm) 
Baseline* 0.72 _+ 0.1 0.94 _+ 0.1 
Residual (after atherectomy) 1.38 _+ 0.1 1.54 _+ 0.1 
Final 2.27 _+ 0.1 2.44 _+ 0.1 
Diameter stenosis (%) 
Baseline* 82 _+ 2 74 _+ 1 
Residual (after atherectomy)* 64 _+ 3 57 +_ 2 
Final* 40 _+ 3 32 _+ 2 
Final device diameter (ram) 2.2 _+ 0.1 2.2 ± 0.1 
D/A* 0.59 _+ 0.02 0.65 _+ 0.01 
RLD/Dt 0.61 ± 0.04 0.70 _+ 0.03 
Final balloon diameter (mm) 3.60 +- 0.1 3.70 + 0.1 
B/A 0.99 -+ 0.1 1.02 -+ 0.1 
FLD/B* 0.60 -+ 0.25 0.68 -+ 0.24 
*p < 0.05, tp = 0.08, comparing Group 1 and Group 2. Data are expressed 
as mean value +_ SD. B/A = ratio of final balloon diameter to reference diameter 
(balloon sizing index); D/A - ratio of final device diameter to reference 
diameter (device sizing index); FLD/B = ratio of final umen diameter tofinal 
balloon diameter (balloon elficiency ratio); RLD/D = ratio of residual lumen 
diameter (after transluminal extraction coronary atberectomy) to final device 
diameter (transluminal extraction coronary atherectomy efficiency index). 
ratios (sizing indexes) and lower efficiency of lumen enlarge- 
ment (RLD/D) in Group 1. Final angiographic success was 
achieved in 84% of the lesions and clinical success in 81%. 
However, the rates of angiographic success (75% vs. 89%, p = 
0.03) and clinical success (69% vs. 88%, p < 0.01) were lower 
in Group 1 than in Group 2, indicating a less favorable 
outcome in lesions with thrombus. 
Angiographic assessment of thrombus extraction. By def- 
inition, baseline angiography revealed intraluminal filling de- 
fects consistent with thrombus in all lesions in Group 1. In 
these lesions, angiography revealed persistent filling defects 
consistent with residual thrombus or dissection, or both, in 
26% of lesions after extraction coronary atherectomy and 12% 
of lesions after adjunctive coronary angioplasty. In contrast, 
new intraluminal filling defects were observed in 3% of Group 
2 lesions after atherectomy and 0.8% after adjunctive angio- 
plasty. The incidence of new or persistent filling defects was 
significantly higher after atherectomy and after angioplasty for 
Group I lesions (p < 0.001). Adjunctive intracoronary throm- 
bolytic therapy (urinokase, 250,000 to i million U) was admin- 
istered in 39% of Group 1 lesions and in 6% of Group 2 lesions 
(p < 0.0001), but the use of oral sodium warfarin (Coumadin) 
at the time of discharge was similar (66% of Group 1 and 50% 
of Group 2). 
Angiographic omplications (Table 4). Abrupt closure and 
distal embolization occurred in 4% and 7% of lesions respec- 
tively, but there were no differences between the two groups. 
Coronary perforation was not observed in any vein graft 
lesions. Overall, no reflow was observed in 17 lesions (9%) but 
its frequency was significantly higher in Group 1 than in Group 
Table 4. Angiographic and Clinical Complications of Transluminal 
Extraction Coronary Atherectomy in Vein Graft Lesions 
Total Group 1 Group 2 
(n = 183) (n 59) (n = 124) 
No. % No. % No. % 
Angiographic complications 
Abrupt closure 7 4 3 5 4 3 
Distal embolization 12 7 5 8 7 6 
No reflow* 17 9 11 19 6 5 
Perforation 0 0 0 0 0 0 
Clinical complications 
Death 3 2 1 2 2 2 
CABG 1 0.5 I 2 0 0 
Q wave MIt 4 2 4 6 1 1 
Non-Q wave MI 4 2 2 4 2 2 
IABP 9 5 4 7 5 4 
Vascular repair* 2 1 2 4 0 0 
Transfusion 9 5 4 6 5 4 
CNS event 4 2 2 4 2 2 
*p < 0.05; tp = 0.09 if patients presenting with acute myocardial infarction 
are excluded, comparing Group 1 and Group 2. CABG = coronary artery bypass 
grafting; CNS event = stroke or transient ischemic attack; IABP = intraaortic 
balloon pump; MI = myocardial nfarction. 
2 (19% vs. 5%, p < 0.05). Furthermore, the frequency of no 
reflow was still higher in Group 1 even when patients who 
presented with acute myocardial infarction were excluded from 
analysis (16% vs. 5%, p < 0.05). 
Clinical complications (Table 4). Overall, the composite 
end point of death, coronary bypass grafting and Q wave 
myocardial infarction occurred in 11 patients (6%). However, 
the composite nd point was more frequent in Group 1 than in 
Group 2 patients (13.3% vs. 2.4%, p < 0.01). After exclusion of 
patients who presented with acute myocardial infarction, there 
was a trend toward a higher frequency of Q wave myocardial 
infarction in Group I than in Group 2 patients (6% vs. 1%, p = 
0.09). Although the need for vascular repair was more frequent 
in Group 1 patients (4% vs. 0%, p < 0.05), this need may have 
been associated with the use of adjunctive thrombolytic ther- 
apy (39% vs. 6%, p < 0.0001). 
Follow-up. Complete clinical follow-up was available in 130 
(92%) of 141 patients discharged from the hospital after 
successful atherectomy. Group 1 and 2 patients were similar 
with respect o angina class (class 0 in 45% and 34%, class 1 to 
2 in 13% and 27%, class 3 in 23% and 20% and class 4 in 19% 
and 18%, respectively; p = NS) at an average follow-up 
interval of 6.0 +_ 2.1 months after discharge. The hierarchical 
incidence of late cardiac events was similar for both groups, 
including recurrent angina treated medically in 16% and 23%, 
repeat percutaneous intervention on the original target lesion 
in 26% and 27%, pereutaneous intervention on a new lesion in 
4% and 3%, coronary bypass urgery in 3% and 9%, Q wave 
infarction in 6% and 3% and late death in 0% and 1.5%, 
respectively. Clinical restenosis, defined as repeat intervention 
(percutaneous procedure or coronary artery bypass grafting) 
on the original target lesion, Q wave infarction or death, 
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Figure 1. Cumulative frequency distribution ofthe follow-up diameter 
stenoses after transluminal extraction coronary atherectomy. Top 
panel, comparison fGroup 1 (lesions with thrombus [ olid line]) and 
Group 2 (lesions without hrombus [dashed line]). Bottom panel, 
comparison of patients discharged without [solid iinel and with 
[dashed linel sodium warfarin therapy. 
occurred in 35% of Group 1 patients and 40.5% of Group 2 
patients (p = NS). 
Angiographic follow-up was available on 110 (74%) of 148 
eligible lesions. As assessed by a dichotomous angiographic 
definition of restenosis (follow-up diameter stenosis >50%), 
the restenosis rate was 58% in Group 1 and 74% in Group 2 
(p = 0.11). The cumulative frequency distribution of follow-up 
diameter stenosis was similar for both groups (Fig. 1, top), and 
the incidence of late total vessel occlusion was similar for both 
groups (35% and 22%, p = NS). The cumulative frequency 
distribution of follow-up diameter stenosis was also similar for 
patients discharged with or without sodium warfarin (Fig. 1, 
bottom). 
Discussion 
Interventional pproaches tothrombotic vein grafts. The 
optimal interventional strategies for stenotic saphenous vein 
bypass graft lesions are unknown. Coronary angioplasty ofvein 
graft lesions is associated with reduced procedural success, 
increased complications and high rates of recurrence (13), and 
these unsatisfactory results are frequently associated with older 
(>4 to 6 years) degenerated grafts and intragraft hrombus 
(8,14). Chronically occluded vein grafts appear to have the 
highest rates of complications, reocclusion and restenosis (9), 
and although adjunctive thrombolytic therapy may be useful 
for immediate revascularization, there is still a high incidence 
of bleeding, myocardial infarction and reocclusion (14). 
Thrombus in native vessels and vein grafts is also associated 
with an increased risk of major complications after interven- 
tions with new devices (15). Although the presence of intralu- 
minal thrombus has generally been a contraindication to the 
use of metallic stents, some stents have been implanted in old 
degenerated grafts with a high angiographic success rate and 
low rate of in-hospital complications (16). Directional coro- 
nary atherectomy has also been used in saphenous vein graft 
lesions with high procedural success rates, but complications 
include myocardial infarction in 4.4% to 9.7% and distal 
embolization in up to 11% of lesions (1%19). The excimer 
laser has been used with high angiographic success rates, but 
distal embolization and myocardial infarction occurred in 4.4% 
of patients (13,20). These data suggest hat the use of new 
devices in vein grafts is also associated with significant angio- 
graphic and clinical complications, possibly because of the 
frequency of thrombus in such lesions. 
Use of transluminal extraction coronary atherectomy. The 
most important finding of this study is that vein graft lesions 
with thrombus are at higher risk after transluminal extraction 
coronary atherectomy than are vein grafts without hrombus. 
Although extraction coronary atherectomy has been advocated 
for treatment of saphenous vein graft lesions (10), its relative 
efficacy compared with that of coronary angioplasty or other 
procedures i unknown. By angiography, filling defects consis- 
tent with thrombus were removed in 74% of lesions immedi- 
ately after extraction coronary atherectomy, which is similar to 
angioscopic studies that demonstrated thrombus extraction in 
75% of lesions after the procedure (21). The failure of 
extraction coronary atherectomy to achieve 100% efficacy of 
thrombus removal is probably related to several factors, in- 
cluding the size mismatch between the largest transluminal 
extraction catheter cutter (2.5 mm) and the diameter of most 
saphenous vein grafts; differential effects on fresh globular 
thrombus compared with old laminated thrombus; and the 
forward cutting mechanism of action, which may limit effec- 
tiveness. Despite its demonstrated ability to remove thrombus, 
extraction coronary atherectomy did not eliminate angio- 
graphic and clinical complications in these high risk lesions. 
However, the degenerated vein graft lesions treated with this 
procedure were more complex than vein graft lesions treated 
with balloon angioplasty or other new devices. 
These findings are similar to those of the New Approaches 
to Coronary Intervention (NACI) Registry, which reported 
similar angiographic (83%) and clinical success rates (71%) 
and major complication rates (9%) for extraction coronary 
atherectomy in vein grafts, in which 51% of lesions had 
angiographic evidence for thrombus (20). In another prelimi- 
nary study of extraction coronary atherectomy from the NACI 
Registry, distal embolization occurred in 8.7% of vein graft 
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lesions and was associated with presence of thrombus and 
baseline total occlusion (22). 
In the present study, angiographic thrombus was also 
associated with reduced angiographic success. In another study 
of extraction coronary atherectomy in 51 lesions in native 
vessels and bypass grafts, the presence of thrombus was 
associated with a procedural success rate of only 63% (23). 
These results may be partially explained by use of undersized 
devices and less aggressive atherectomy. However, even after 
correcting for differences in device size, the efficiency of 
transluminal extraction catheter atherectomy-mediated lumen 
enlargement (RLD/D) was lower in the thrombus group. The 
presence of thrombus was associated with more Q wave 
myocardial infarction even after excluding patients who pre- 
sented with acute myocardial infarction. 
Late outcome. As previously reported (11), extraction cor- 
onary atherectomy in vein grafts was associated with a high 
incidence of angiographic and clinical restenosis, late vessel 
occlusion and need for late revascularization. The presence of 
thrombus at the time of the original procedure or the use of 
oral Coumadin did not appear to have any impact on late 
angiographic results. Because of the unsatisfactory immediate 
and long-term results of percutaneous intervention in degen- 
erated vein grafts, repeat coronary bypass surgery is a frequent 
consideration. However, perioperative mortality rates are two- 
to fourfold higher for a repeat procedure than for initial 
elective bypass surgery (24-31), and although total survival at 
5 years is 84% to 94%, the event-free survival rate is only 50% 
(25,28). 
Limitations of study. This study has several imitations. 1) 
It is a retrospective study and as such is subject to the same 
limitations of all retrospective studies. 2) There was no control 
group treated with coronary angioplasty to allow direct com- 
parison of efficacy and safety. However, many of these lesions 
were considered unsuitable for angioplasty or other proce- 
dures because of severe graft degeneration. 3) Angiography is 
a relatively inaccurate method for detecting thrombus, partic- 
ularly in old degenerated vein grafts with friable atherothrom- 
botic material. The strict definition of thrombus in this study 
may have underestimated its true incidence. 4) The assessment 
of lumen enlargement itself may be less important than the 
degree of thrombus removal for lesions with thrombus. Unfor- 
tunately, the angiographic assessment of thrombus removal is 
unreliable. 5) The study size and low incidence of angiographic 
and clinical complications limit the interpretation of compar- 
isons that are not statistically significant (beta error). 
Conclusions. In patients undergoing transluminal extrac- 
tion coronary atherectomy of stenoses in saphenous vein 
grafts, angiographic evidence of thrombus was associated with 
the clinical presentation of acute myocardial infarction and 
angiographic evidence of total occlusions and diffuse disease. 
Compared with results in lesions without thrombus, results of 
extraction coronary atherectomy of vein graft lesions with 
thrombus were characterized by reduced procedural success 
and increased risk of no refiow, Q wave myocardial infarction, 
vascular surgical repair and the need for adjunctive intracoro- 
nary thrombolytic therapy. 
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